Tranexamic Acid TRANEXAMIC ACID EMCURE PHARMACEUTICALS LIMITED FDA Approved INDICATIONS AND USAGE Tranexamic acid injection, USP is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.
FunFoxMeds bottle
Substance Tranexamic Acid
Route
INTRAVENOUS
Applications
ANDA203521
Package NDC

Drug Facts

Composition & Profile

Quantities
10 ml
Treats Conditions
Indications And Usage Tranexamic Acid Injection Usp Is Indicated In Patients With Hemophilia For Short Term Use 2 To 8 Days To Reduce Or Prevent Hemorrhage And Reduce The Need For Replacement Therapy During And Following Tooth Extraction

Identifiers & Packaging

Container Type BOTTLE
All Product Codes
UPC
0314593318016
UNII
6T84R30KC1
Packaging

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 14593-318-01 Tranexamic Acid Injection, USP 1000 mg/10 mL (100 mg/mL) Intravenous Use Only Rx only 10 mL Single-Dose Vial label

Package Descriptions
  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 14593-318-01 Tranexamic Acid Injection, USP 1000 mg/10 mL (100 mg/mL) Intravenous Use Only Rx only 10 mL Single-Dose Vial label

Overview

INDICATIONS AND USAGE Tranexamic acid injection, USP is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.

Indications & Usage

Tranexamic acid injection, USP is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.

Dosage & Administration

Not available

Warnings & Precautions
No warnings available yet.

Similar Drugs

Related medications based on brand, generic name, substance, active ingredients.

View all similar drugs →